title: Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples.
abstract: Atorvastatin calcium (ATC), an anti-lipid BCS class II drug, is marketed in crystalline and amorphous solid forms. The objective of this study was to perform solid state characterization of commercial crystalline and amorphous ATC drug samples available in the Indian market. Six samples each of crystalline and amorphous ATC were characterized using X-ray powder diffractometry (XRPD), differential scanning calorimetry (DSC), thermogravimetric analysis, Karl Fisher titrimetry, microscopy (hot stage microscopy, scanning electron microscopy), contact angle, and intrinsic dissolution rate (IDR). All crystalline ATC samples were found to be stable form I, however one sample possessed polymorphic impurity, evidenced in XRPD and DSC analysis. Amongst the amorphous ATC samples, XRPD demonstrated five samples to be amorphous 'form 27', while, one matched amorphous 'form 23'. Thermal behavior of amorphous ATC samples was compared to amorphous ATC generated by melt quenching in DSC. ATC was found to be an excellent glass former with T(g)/T(m) of 0.95. Residual crystallinity was detected in two of the amorphous samples by complementary use of conventional and modulated DSC techniques. The wettability and IDR of all amorphous samples was found to be higher than the crystalline samples. In conclusion, commercial ATC samples exhibited diverse solid state behavior that can impact the performance and stability of the dosage forms.
authors.affiliation: Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research, Sector 67, SAS Nagar, Punjab, 160 062, India.
authors.forename: Ganesh
authors.initials: G
authors.lastname: Shete
authors.forename: Vibha
authors.initials: V
authors.lastname: Puri
authors.forename: Lokesh
authors.initials: L
authors.lastname: Kumar
authors.forename: Arvind K
authors.initials: AK
authors.lastname: Bansal
mesh_terms: D000924:Anticholesteremic Agents / Q000737:chemistry; D000069059:Atorvastatin; D003460:Crystallization; D004353:Drug Evaluation, Preclinical; D004355:Drug Stability; D006538:Heptanoic Acids / Q000737:chemistry*; D008968:Molecular Conformation; D011208:Powders; D011758:Pyrroles / Q000737:chemistry*; D012995:Solubility
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011208:Powders; D011758:Pyrroles; D000069059:Atorvastatin